Crossover Trial of AD109 in Obstructive Sleep Apnea

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a randomized, 4-period, placebo-controlled, crossover, phase 2 clinical study to examine the efficacy and safety of AD109 versus its individual components or placebo in patients with obstructive sleep apnea.
Epistemonikos ID: 67da6e5b09989bc2d0e0f3d5c52d2a4491b6e3c8
First added on: May 07, 2024